| Business Name: |
Hamedaninia Azar M D |
| Address: |
865 3rd Avenue # 101, Chula Vista, California 91911 |
| Phone Number: |
(619) 426-7910 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Physicians Offices |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
Eugene J Basiliere M D - Chula Vista, CA 91911
Xray Medical Group Radiation Oncology - Chula Vista, CA 91911
Hamedaninia Azardokht MD - Chula Vista, CA 91911
James Stokos Md - Chula Vista, CA 91911
Tiznado-Garcia Ernesto MD - Chula Vista, CA 91911
Lance L Altenau M D - Chula Vista, CA 91911
Chu Neelina V MD - Chula Vista, CA 91911
Sharp Hospital - Chula Vista, CA 91911
Lance Altenau Md - Chula Vista, CA 91911
Kurosu Catherine J MD - Chula Vista, CA 91911
Cordoba Miguel MD - Chula Vista, CA 91911
Prabhu Ravindra MD - Chula Vista, CA 91911
Chang Irene MD - Chula Vista, CA 91911
Desta Taddese M D - Chula Vista, CA 91911
Md Tim Dabfm Gurtch - Chula Vista, CA 91911
Avila Patricia M D - Chula Vista, CA 91911
Robert L Martin Dr - Chula Vista, CA 91911
Gastroenterology Associates - Chula Vista, CA 91911
Dr Burquez - Chula Vista, CA 91911
Irene S Fu M D - Chula Vista, CA 91911
|
The company Hamedaninia Azar M D provides B2C services in the form of Physicians Offices from its single location in California.
1 to 4 employees work for Hamedaninia Azar M D, and the business now earns $100.000 to $499.999 per annum.
Hamedaninia Azar M D was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Hamedaninia Azar M D, please call with the phone number (619) 426-7910 or visit its single location at 865 3rd Avenue # 101 in Chula Vista, California 91911.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.